Detection of mutagenicity of the colon carcinogen 1,2-dimethylhydrazine by the host-mediated assay and its correlation to carcinogenicity. 1978

M Moriya, and K Kato, and T Ohta, and K Watanabe, and Y Watanabe, and Y Shirasu

Mutagenic potential of 1,2-dimethylhydrazine (DMH) was investigated in the host-mediated assay with mice used as hosts. This assay revealed potent mutagenicity of this colon carcinogen for Salmonella typhimurium G46. The mutagenicity of DMH was inhibited by pretreatment of mice with disulfiram. In addition, mouse strain and sex differences influenced the mutation induction by DMH: Mutation induction was significantly lower in C57BL/6 mice than in outbred ICR mice of either sex and was generally higher in male than in females of either C57BL/6 or ICR mice.

UI MeSH Term Description Entries
D008297 Male Males
D008763 Methylhydrazines Hydrazines substituted by one or more methyl groups in any position.
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004127 Dimethylhydrazines Hydrazines substituted with two methyl groups in any position. Dimethylhydrazine
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005260 Female Females

Related Publications

M Moriya, and K Kato, and T Ohta, and K Watanabe, and Y Watanabe, and Y Shirasu
October 1986, Cancer research,
M Moriya, and K Kato, and T Ohta, and K Watanabe, and Y Watanabe, and Y Shirasu
January 2020, Mutation research. Genetic toxicology and environmental mutagenesis,
M Moriya, and K Kato, and T Ohta, and K Watanabe, and Y Watanabe, and Y Shirasu
October 1979, Cancer letters,
M Moriya, and K Kato, and T Ohta, and K Watanabe, and Y Watanabe, and Y Shirasu
August 1988, Biochemical pharmacology,
M Moriya, and K Kato, and T Ohta, and K Watanabe, and Y Watanabe, and Y Shirasu
November 2004, Mutation research,
M Moriya, and K Kato, and T Ohta, and K Watanabe, and Y Watanabe, and Y Shirasu
November 1988, Archives of biochemistry and biophysics,
M Moriya, and K Kato, and T Ohta, and K Watanabe, and Y Watanabe, and Y Shirasu
September 1983, Cancer,
M Moriya, and K Kato, and T Ohta, and K Watanabe, and Y Watanabe, and Y Shirasu
January 1978, Verhandlungen der Deutschen Gesellschaft fur Pathologie,
M Moriya, and K Kato, and T Ohta, and K Watanabe, and Y Watanabe, and Y Shirasu
June 1980, The Tokushima journal of experimental medicine,
M Moriya, and K Kato, and T Ohta, and K Watanabe, and Y Watanabe, and Y Shirasu
January 1972, Chemico-biological interactions,
Copied contents to your clipboard!